Knowledge

Our knowledge resources reflect the breadth and depth of our expertise, our insight into the issues which matter to your business, and our understanding of the markets in which you operate.

Knowledge

<p>Filter Knowledge</p>

  • Filter Knowledge

    Articles Filtering:

2750 Results

Brexit: should we stay or should we go?

Brexit is the subject of the moment and as we gear up for the referendum on Britain’s membership of the European Union the debate is coming to our London offices on Wednesday, 16 March.

£162 million IPO for Shield Therapeutics

Travers Smith corporate finance partner Richard Spedding and corporate finance senior associate Mark Anderson have advised Liberum Capital Limited (as nominated adviser and sole bookrunner) to Shield Therapeutics plc (“Shield Therapeutics”), on its £162 million IPO. 

Camden Market owner moves from AIM to the Main Market

Travers Smith partner Andrew Gillen and senior corporate associate Andrew Gofton-Salmond advised Canaccord Genuity and Shore Capital in their capacity as joint financial advisers to Market Tech Holdings Limited ("Market Tech") in connection with the cancellation of trading of Market Tech’s shares on AIM and admission of its shares to the Official List and to trading on the London Stock Exchange's main market for listed securities.

Leading human resources software firm CoreHR receives strategic growth investment

A Travers Smith team led by private equity partner, Helen Croke, has advised the founders of CoreHR, a leading provider of cloud-based human capital management (“HCM”) and payroll software, on a strategic growth investment from JMI Equity, a growth equity firm focused on investing in leading software and services companies, and JMI Services LLC, which is the family investment company of John J. Moores.

Back To Top Back To Top chevron up